Evaluation of the update on screening for retinopathy of prematurity in a tertiary care center in Türkiye with retrospective cohort
Turkish Journal of Medical Sciences · 10.12.2024 · 54 (6) · 1295-1301
DOI: 10.55730/1300-0144.5912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 10.12.2024. Verfasst von Emine Kaya Güner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, University of Health Sciences, Tepecik Research and Training Hospital, İzmir, Turkiye. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Neonatal Screening, Tertiary Care Centers. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: In Turkey, recommendations for screening for retinopathy of prematurity (ROP) have been updated in 2021. Herein, we aimed to present detailed data on the infants included in the screening according to the new criteria and evaluate whether these changes benefit in detecting severe ROP.Materials and Methods: Our hospital's medical records of babies screened for ROP between July 2019 - July 2021 and August 2021 - August 2023 were retrospectively examined. Gestational age (GA), birth weight (BW), gender of the babies, whether there was a multiple pregnancy, ROP examination results, the most advanced ROP level and time, and ROP treatment needs and times were recorded. Cohort data from these two time periods were compared before and after the update.
Results
Three hundred and fifty-seven babies screened before the guideline update and 336 babies screened after were included. Between August 2021 - 2023, more ROPs were detected (19.3% and 21.4% for both cohorts, respectively), while a lower rate of treatment was required (3.9% and 2.1% for both cohorts, respectively). Since one of the babies treated after the update was included in the screening with the new GA criterion. In both cohorts, no infant needed treatment before 32 weeks of postmenstruel age, regardless of GA at birth agreement.
Conclusion
In our study a baby in need of treatment who was not included in screening according to the previous criteria was identified. The data we obtained supports the necessity of increasing the GA upper limit. Additionally, the 31st week seems safe for the beginning of the examination in extremely premature babies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, University of Health Sciences, Tepecik Research and Training Hospital, İzmir, Turkiye.
ORCID-Profile: Emine Kaya Güner, Duygu Inci Bozbiyik
Zitieren
APA
Kaya Güner, E., & Inci Bozbiyik, D. (2024). Evaluation of the update on screening for retinopathy of prematurity in a tertiary care center in Türkiye with retrospective cohort. Turkish Journal of Medical Sciences, 54(6), 1295-1301. https://doi.org/10.55730/1300-0144.5912
Vancouver
Kaya Güner E, Inci Bozbiyik D. Evaluation of the update on screening for retinopathy of prematurity in a tertiary care center in Türkiye with retrospective cohort. Turkish Journal of Medical Sciences. 2024;54(6):1295-1301. doi:10.55730/1300-0144.5912
BibTeX
@article{KayaGner2024,
author = {Kaya Güner, Emine and Inci Bozbiyik, Duygu},
title = {Evaluation of the update on screening for retinopathy of prematurity in a tertiary care center in Türkiye with retrospective cohort},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {6},
pages = {1295--1301},
doi = {10.55730/1300-0144.5912}
}
EUVIMED